Surgical removal of the epileptogenic tissue or implantation of a stimulation device represents the best chance for patients with pharmacoresistant epilepsy to be seizure-free. Intracranial EEG acquisition, processing, and machine learning techniques have undergone rapid development and shown promise in the localization of epileptogenic tissue and seizure prediction. However, the transition of these methods into the clinic is slow even though the computational power of computers is sufficient.